Green_2005_Pharmacoeconomics_23_1271

Reference

Title : Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease - Green_2005_Pharmacoeconomics_23_1271
Author(s) : Green C , Picot J , Loveman E , Takeda A , Kirby J , Clegg A
Ref : Pharmacoeconomics , 23 :1271 , 2005
Abstract : Green_2005_Pharmacoeconomics_23_1271
ESTHER : Green_2005_Pharmacoeconomics_23_1271
PubMedSearch : Green_2005_Pharmacoeconomics_23_1271
PubMedID: 16336020

Related information

Citations formats

Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2005)
Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease
Pharmacoeconomics 23 :1271

Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2005)
Pharmacoeconomics 23 :1271